ClearPoint Neuro

Executive Summary

ClearPoint Neuro is a private medical device company providing a global therapy-enabling platform for precise navigation and delivery to the brain. Founded in 1998 and based in Solana Beach, CA, the company's proprietary technology addresses the critical need for accuracy in neurosurgical procedures, including drug delivery, gene therapy, and ablation. As a pre-clinical stage company, ClearPoint Neuro focuses on developing its platform to support a range of therapeutic applications, potentially reducing invasiveness and improving outcomes. The company's solution leverages real-time imaging and software to guide instruments to targeted brain regions, offering a versatile platform that can be adapted for multiple indications. With a strong intellectual property portfolio and partnerships with leading research institutions, ClearPoint Neuro is positioned to become a key enabler in the growing field of neurosurgery and brain therapeutics.

Upcoming Catalysts (preview)

• Q3 2026FDA Clearance for Expanded Indication60% success
• Q4 2026Strategic Partnership with Major Pharma50% success
• Q2 2027First Clinical Trial Results for Gene Therapy Delivery40% success